Cormorant Asset Management, LP

Q3 2026 13F-HR Holdings

Location
Boston, MA
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
60
Total value ($000)
$1,489,259
Net value change ($000)
-462,147 (-23.7%)
New positions
13
Sold out positions
3
Turnover %
21.6%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
BLOSSOMHILL THERAPEUTICS INC 67,366 NEW
ELECTRA THERAPEUTICS INC 37,862 NEW
ATTOVIA THERAPEUTICS INC 30,660 NEW
LATIGO BIOTHERAPEUTICS INC 30,323 NEW
IRD 26,620 NEW
SNSE 22,924 299.4%
PARABILIS MEDICINES INC 22,709 18.0%
FREENOME INC 22,539 NEW
ADARX PHARMACEUTICALS INC 19,200 NEW
ANL 17,902 39.1%
Top Reduces (Value $000, Stocks/ETFs)
EYPT -81,297 -81.2%
ALMS -77,123 -83.4%
PRAX -68,651 -32.0%
BBOT -62,933 -46.2%
ABVX -47,867 -53.2%
BIOA -42,708 -72.9%
ERAS -36,620 -33.3%
DNTH -29,085 -39.8%
MLTX -29,001 -46.5%
RAPP -28,166 -25.4%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type